Genmab — August 2018

[bibob]

God morgen.

[jkj]

jo det er nyt peter, kan måske tolkes positivt i forhold til evt. patent krængelse.

[Sukkeralf]

Det lader i hvert fald til at MorphoSys ikke længere ser nogen mulighed for partneraftale af nogen art - om der kan drages nogle konklutioner i retning af patentsagen er mere tvivlsomt, tænker jeg.

[Legolas23]

Lignede det ikke også at MOR202 blev kørt frem som et PR stunt for at argumentere for, de havde aktiviteter i MM af hensyn til retssagen?

[E_L]

EMA expects a staff loss of about 30% due to Brexit. As if they weren´t slow enough… http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2018/08/news_detail_002999.jsp&mid=WC0b01ac058004d5c1

[E_L]

article on Cost-effectiveness of Drugs to Treat Relapsed/Refractory Multiple Myeloma in the United States. https://www.ncbi.nlm.nih.gov/pubmed/?term=29290170

[E_L]

However, only the addition of DAR or PAN may be considered cost-effective options according to commonly cited thresholds

[E_L]

the article is from januari, but hey, it is Agurketid
full text https://www.jmcp.org/doi/10.18553/jmcp.2018.24.1.29

[Raffles]

Preclinical evaluation of DuoBody CD3xCD20 to be presented by Ida Hiemstra 14th November 14:35 at conference in Lisbon https://www.pegsummiteurope.com/advancing-bispecifics

[E_L]

That link hints that you are correct that the first patient may have been dosed - A clinical study evaluating the DuoBody-CD3xCD20 is currently enrolling.

[E_L]

Optimizing Early Sequencing and Treatment in MM https://www.onclive.com/peer-exchange/myeloma-next-gen-regimens/optimizing-early-sequencing-and-treatment-in-mm

[bibob]

God morgen.

[ienk1]

Page not found - Myeloma Patients Europe

Myeloma Patients Europe (www.mpeurope.org)

[ienk1]

så skal vi nok kun 1 %ned i dag

[Helge_LarsenPI-redaktør]

God morgen og tak til lenk1.

[transalp]

Go morgen

[hda]

Siden findes ikke

(borsen.dk)

[royal]

JnJ har måske presset dem?

[Mcjean]

Konkurrent? som at sammenligne en gennemsnits-feminist begavelse med et normalt begavet individ, det giver ingen mening, forskellen måles i hele galakseafstande.

[Repsac]

Jeg tror ikke at JnJ har presset dem. De har bare ikke pengene til at fortsætte.